World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
84
Citations
29447
World Ranking
14981
National Ranking
7572

Overview

Nicola A. Hanania is affiliated with Baylor College of Medicine in the United States. Their research primarily focuses on pulmonary and respiratory medicine, with a significant body of work spanning several interconnected disciplines including physiology, immunology, allergy, and surgery.

The scientist's research topics cover a variety of respiratory and immunological areas. Prominent themes include:

  • Asthma and respiratory diseases
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Respiratory and Cough-Related Research
  • Inhalation and Respiratory Drug Delivery
  • Respiratory Support and Mechanisms
  • Allergic Rhinitis and Sensitization
  • IL-33, ST2, and ILC Pathways

Nicola A. Hanania has contributed to multiple high-impact research papers, notable recent examples include:

  • "Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts," 2023, New England Journal of Medicine
  • "Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma," 2020, Allergy
  • "EAACI Biologicals Guidelines-Recommendations for severe asthma," 2020, Allergy
  • "Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial," 2020, The Lancet Respiratory Medicine
  • "Severe Monkeypox in Hospitalized Patients - United States, August 10-October 10, 2022," 2022, MMWR Morbidity and Mortality Weekly Report

Frequent co-authors collaborating with Nicola A. Hanania include:

  • Elizabeth A. Regan
  • Barry J. Make
  • Surya P. Bhatt
  • Edwin K. Silverman
  • Alberto Papi

Hanania has published extensively in prominent venues within the respiratory and allergy fields. These include:

  • CHEST Journal
  • Respiratory Medicine
  • The Journal of Allergy and Clinical Immunology In Practice
  • American Journal of Respiratory and Critical Care Medicine
  • Annals of Allergy Asthma & Immunology

Their publication record covers more than 420 works in medicine, with a core focus on pulmonary and respiratory medicine accounting for over 200 publications. Additional notable contributions include studies in physiology and immunology, supporting advancements in treatment strategies and understanding of respiratory diseases.

Best Publications

  • Lebrikizumab Treatment in Adults with Asthma

    Jonathan Corren;Robert F. Lemanske;Nicola A. Hanania;Phillip E. Korenblat

  • Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society

    Amir Qaseem;Timothy J. Wilt;Steven E. Weinberger;Nicola A. Hanania

  • Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study.

    Nicola A. Hanania;Sally Wenzel;Karin Rosén;Hsin-Ju Hsieh

  • Anxiety and Depression in COPD: Current Understanding, Unanswered Questions, and Research Needs

    Janet Maurer;Venkata Rebbapragada;Soo Borson;Roger Goldstein

  • Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial.

    Nicola A. Hanania;Oral Alpan;Daniel L. Hamilos;John J. Condemi

  • Chronic Obstructive Pulmonary Disease Exacerbations in the COPDGene Study: Associated Radiologic Phenotypes

    MeiLan K. Han;Ella A. Kazerooni;David A. Lynch;Lyrica X. Liu

  • Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials

    Nicola A Hanania;Phillip Korenblat;Kenneth R Chapman;Kenneth R Chapman;Eric D Bateman

  • The Efficacy and Safety of Fluticasone Propionate (250 μg)/Salmeterol (50 μg) Combined in the Diskus Inhaler for the Treatment of COPD

    Nicola A. Hanania;Patrick Darken;Donald Horstman;Colin Reisner

  • Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies

    Nicola A Hanania;Michael Noonan;Jonathan Corren;Phillip Korenblat

  • Radiation-Induced Lung Injury: Assessment and Management.

    Alexander N. Hanania;Walker Mainwaring;Yohannes T. Ghebre;Nicola A. Hanania

  • Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort.

    Nicola A. Hanania;Hana Müllerova;Nicholas W. Locantore;Jørgen Vestbo;Jørgen Vestbo

  • Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials

    Mark T Dransfield;Jean Bourbeau;Paul W Jones;Nicola A Hanania

  • Revisiting Type 2‐high and Type 2‐low airway inflammation in asthma: current knowledge and therapeutic implications

    D. Robinson;M. Humbert;R. Buhl;A. A. Cruz

  • Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma

    Ioana Agache;Jessica Beltran;Cezmi Akdis;Mubeccel Akdis

  • Bronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthma

    Michael E. Wechsler;Michel Laviolette;Adalberto S. Rubin;Jussara Fiterman

  • Prevention of Acute Exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline

    Gerard J. Criner;Jean Bourbeau;Rebecca L. Diekemper;Daniel R. Ouellette

  • Medical Personnel's Knowledge of and Ability to Use Inhaling Devices: Metered-Dose Inhalers, Spacing Chambers, and Breath-actuated Dry Powder Inhalers

    Nicola A. Hanania;Richard Wittman;Steven Kesten;Kenneth R. Chapman

  • Adverse effects of inhaled corticosteroids

    Nicola A. Hanania;Kenneth R. Chapman;Steven Kesten

  • Asthma in the Elderly: Current Understanding and Future Research Needs: A Report of a National Institute on Aging (NIA) Workshop

    Nicola A. Hanania;Monroe J. King;Sidney S. Braman;Carol Saltoun

  • Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease

    Mark T. Dransfield;Mark T. Dransfield;Ken M. Kunisaki;Ken M. Kunisaki;Matthew J. Strand;Antonio Anzueto;Antonio Anzueto

Frequent Co-Authors

Robert A. Wise
Robert A. Wise Johns Hopkins University School of Medicine
Mark T. Dransfield
Mark T. Dransfield University of Alabama at Birmingham
Fernando J. Martinez
Fernando J. Martinez University of Massachusetts Chan Medical School
Barry J. Make
Barry J. Make National Jewish Health
MeiLan K. Han
MeiLan K. Han University of Michigan–Ann Arbor
Gerard J. Criner
Gerard J. Criner Temple University
Edwin K. Silverman
Edwin K. Silverman Brigham and Women's Hospital
Russell P. Bowler
Russell P. Bowler Cleveland Clinic
Jeffrey L. Curtis
Jeffrey L. Curtis University of Michigan–Ann Arbor
Nadia N. Hansel
Nadia N. Hansel Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering Medicine in the USA opens doors to a range of online degrees and healthcare career options. Prospective students who want to start with nursing might benefit from exploring the easiest bsn program to get into, which can help speed up the process of becoming a registered nurse.

For those interested in non-clinical roles, online medical billing and coding with financial aid offers flexibility, affordability, and quick entry into the healthcare field. Many schools now provide accredited programs online, making it easier to balance study with work or other commitments.

If standardized test requirements are a concern, you may consider nursing schools that don't require teas test, which offer alternative pathways to nursing programs.

Plus, students seeking leadership roles in healthcare can look into a healthcare administration online degree to prepare for management positions. These options broaden the scope for anyone pursuing a medical or allied health career in the USA.

Best Scientists Citing Nicola A. Hanania

Trending Scientists

Recently Published Articles